𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cognitive impairment in myotonic dystrophy type 1 (DM1)

✍ Scribed by A. Modoni; G. Silvestri; M. Gabriella Vita; D. Quaranta; P. A. Tonali; C. Marra

Publisher
Springer
Year
2008
Tongue
English
Weight
179 KB
Volume
255
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Improved method for molecular diagnosis
Improved method for molecular diagnosis of myotonic dystrophy type 1 (DM1)
✍ Nihan Erginel-Unaltuna; Fahri Akbas πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 180 KB

## Abstract Myotonic dystrophy type 1 (DM1) has been identified as the amplification of a polymorphic (CTG)n repeat in the 3β€² untranslated region of a gene encoding a serine/threonine kinase (DMPK). The length of the CTG repeat correlates with clinical severity and the age at onset of the disease.

Therapeutics development in myotonic dys
Therapeutics development in myotonic dystrophy type 1
✍ Erin Pennock Foff; Mani S. Mahadevan πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 238 KB

## Abstract Myotonic dystrophy (DM1), the most common adult muscular dystrophy, is a multisystem, autosomal dominant genetic disorder caused by an expanded CTG repeat that leads to nuclear retention of a mutant RNA and subsequent RNA toxicity. Significant insights into the molecular mechanisms of R